• High Quality Immunological Assay Kits & Reagents For Research Use
Assaypro
  • Home
  • About Us
    • About Assaypro
    • Career Opportunities
  • Products
    • ELISA Kits
      • AssayMax™ ELISA Kits
      Activity Kits
      • AssaySense Chromogenic Activity Kits
      Fluorescent Kits
      • AssayLite™ Fluorescent Singleplex Kitsnew
      • AssayLite™ Fluorescent Multiplex Kits
      • AssayLite™ FACS Kits
      • AssayLite™ ICC Kits
      Kit Controls
      • Positive Controls
      • Negative Controls
      Antibodies
      • Monoclonal, Primary Antibodies
      • Monoclonal, Secondary Antibodies
      • Polyclonal, Primary Antibodies
      • Polyclonal, Secondary Antibodies
      Deficient Products
      • Deficient Products (Plasma and Serum)
      Proteins
      • Proteins
      Reagents and Equipment
      • Reagents, Equipment
      OVER 10,000+ PRODUCTS AssayLite™ Our patented fluorescent
      multiplex kits.

      US Patent No. 9945847

      LEARN MORE »
      OTHER SERVICES
  • Order
    • Place Order
    • Price Quote
    • Legal Information
  • Contact
    • Contact Us
    • Distributors
    • Technical Support
  • Sign In
    • Sign In
    • Register

Product Details

  • Home
  • Products
  • Product Details

Human Complement C3 AssayMax ELISA Kit

DETAILS
Description: This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Type: AssayMax ™ ELISA Kits
Samples:

   Serum

   Plasma

Catalog Number: EC2101-1
Species: Human
Format: Competitive ELISA
Size: 96 Well Plate
Range: 0.117 - 7.5 ug/ml
Research Area: Lupus (SLE), Autoimmune Disease
Entrez Gene: 718
UniProt: P01024
Synonyms: Complement Component 3, Complement Component III, Complement Factor 3, Complement CIII, CIII, C3, Acylation Stimulating Protein Cleavage Product, AHUS5, ARMD9, ASP, C3 and PZP like alpha 2 Macroglobulin Domain Containing Protein 1, Complement C3c alpha'' Chain Fragment 2, CPAMD 1, CPAMD1, HEL S 62p
Note: For Research Use Only, Not To Be Used For Diagnostic Purposes
Product References:
* Ozawa Y et al. (2021) Changes in serum complements and their regulators in generalized myasthenia gravis. Euro. J. Neuro. 28:314-322.
* Okada K et al. (2021) Serum complement C3 and alpha2-macroglobulin are potentially useful biomarkers for inflammatory bowel disease patients. Heliyon. 7(3): e06554.
* Garcia-Arguinzonis M et al. (2021) Alternative C3 Complement System: Lipids and Atherosclerosis. Int J Mol Sci. 22(10):5122.
* Ella EE et al. (2020) Comparative Widal Reaction for IgG/IgM Complement C3, lymphocyte and Neutrophils Assay in Patients with Suspected Typhoid Fever in Selected Hospitals in Kaduna State, Nigeria. Nig. J. Pure & Appl. Sci. 33(1).
* Andersone BJ (2020) Lymphatic Filariasis: Host and parasite factors and the pathogenesis of systemic adverse events following treatment. Washington University in St. Louis Electronic Theses and Dissertations. 2160.
* Chaika K et al. (2019) The status of the C3 fnd C4 fractions of the complement system in children with Henoch-Schelan purpura. Pediatr Pol. 94 (4): 229-234.
* Andersen BJ et al. (2019) Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis. PLoS Negl Trop Dis. 13(9):e0007697.
* Al-Rayahi IA et al. (2019) Serum IgE Level in Systemic Lupus Erythematosus Associated Nephropathy. Ind. J. Foren. Med. Toxi. Vol. 13(1):247-251.
* Pankratenko TE (2018) Soluble adhesion molecules in children with hemolytic uremic syndrome. Med. Imm. (Russia). 20(6):871-876.
* McMorrow AM et al. (2018) Personalized Cardio-Metabolic Responses to an Anti-Inflammatory Nutrition Intervention in Obese Adolescents: A Randomized Controlled Crossover Trial. Mol Nutr Food Res. 62(10):e1701008.
* Hoefman S et al. (2018) Methods for treating rheumatoid arthritis by administering IL-6 receptor antibodies. United States Patent 10118967
* Yurova BA et al. (2017) Changes in the complement system in membranoproliferative glomerulonephritis. https://doi.org/10.17116/terarkh201789669-77.
* Wasiak S et al. (2017) Downregulation of the complement cascade in vitro, in mice and in patients with cardiovascular disease by the BET protein inhibitor apabetalone (RVX-208). J. of Cardiovasc. Trans. Res. 10:337-347.
* Montoya JI et al. (2017) Coagulation imbalance and neurocognitive functioning in older HIV+ adults on suppressive antiretroviral therapy. AIDS. 31(6): 787-795.
* Mizuno M et al. (2017) High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients. PLoS One. 12(1):e0169111
* Masoudi S et al. (2017) Contact lens?induced discomfort and inflammatory mediator changes in tears. Eye Contact Lens. 43(1):40-45.
* Liu RL et al. (2017) Polydopamine/polyethyleneimine complex adhered to micrometer-sized magnetic carbon fibers for high-efficiency hemoperfusion. J Biomater Sci Polym Ed. 28(14):1444-1468.
* Kaminsky V et al. (2017) Proteflazid and local immunity in diseases caused by human papillomavirus, herpesvirus and mixed urogenital infections. Pol Merkur Lekarski. 42(249):110-115.
* Lonnroth I et al. (2016) Interaction Of Proteasomes And Complement C3, Assay Of Antisecretory Factor In Blood. J Immunoassay Immunochem. 37(1):43-54.
* Jayakumar R et al. (2016) Comparison of Complement component C3 level with bacterial infections in decompensated liver disease patients in a tertiary care hospital. International Journal of Bioassays 5.12: 5128-5132.
* Bryant A et al. (2016) Complement component 3 is associated with metabolic comorbidities in older HIV-positive adults. AIDS Res Hum Retroviruses. 32(3): 271-278.
* Yadav AP et al. (2015) Activation of Complement System during Ship Voyage and Winter-over Expedition in Antarctica. J Marine Sci Res Dev. 5:3.
* Yang YH et al. (2015) The Interaction between Circulating Complement Proteins and Cutaneous Microvascular Endothelial Cells in the Development of Childhood Henoch-Schonlein Purpura. PLoS One. 10(3):e0120411
* Sei Y et al. (2015) Expression of membrane complement regulators, CD46, CD55 and CD59, in mesothelial cells of patients on peritoneal dialysis therapy. Mol Immunol. 65(2):302-9
* Rajeswari J. (2015) A study on bacterial infections and their antimicrobial susceptibility pattern in decompensated liver disease patients in a tertiary care hospital. The Tamilnadu Dr.M.G.R.Medical University.
* Motasem EME (2015) Value of different diagnostic markers in spontaneous bacterial peritonitis in HCV Egyptian cirrhotic patients. Open J. Gastroenterology. 5(9):119-128.
* Menzhinskaya IV et al. (2015) Incidence of Autoantibodies to C1Q Complement Component in Women with Miscarriages and Autoantibodies to Phospholipids and Chorionic Gonadotropin. Bull Exp Biol Med. 160(2):260-3.
* Linde VA et al. (2015) Detection of proteomic markers of endometriosis. J. Obsterics Gynaecology. EP6.45, P.85.
* Hoefman S et al. (2015) Treatment of il-6r related diseases. Patent application: US20190119392A1.
* Yokoyama T et al. (2014) Comparative analysis of serum proteins in relation to rheumatoid arthritis and chronic periodontitis. J Periodontol. 85(1):103-12
* Masoudi S (2014) Changes in tear film biochemistry in end of day ocular discomfort with and without contact lenses. The University of New South Wales. Ph.D. Thesis.
* Kuo SJ et al. (2014) Complement component C3: Serologic signature for osteogenesis imperfecta. Analysis of a comparative proteomic study. Journal of the Formosan Medical Association 1-7.
* Gawad ERA (2014) Role of Anti-nucleosome Antibodies in the Diagnosis of Systemic Lupus Erythematosus and as A Marker for Lupus Nephropathy. THE EGYPTIAN JOURNAL OF IMMUNOLOGY 21(1):57-65
* EI-Gendy NA et al. (2014) Diagnosis of spontaneous bacterial peritonitis. The Egyptian Journal of Internal Medicine 26(2):53-59
* Wen Q et al. (2013) Proteomic analysis in peritoneal dialysis patients with different peritoneal transport characteristics. Biochem Biophys Res Commun. 438(3):473-8.
* Janzer A et al. (2012) Lysine-specific demethylase 1 (LSD1) and histone deacetylase 1 (HDAC1) synergistically repress proinflammatory cytokines and classical complement pathway components. Biochem Biophys Res Commun. 421(4):665-70
* Dowling P et al (2012) Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer. Int J Cancer. 131(4):911-923
* Burillo E et al. (2012) Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome. Lipids Health Dis. 11:116
* Shiirevnyamba A et al. (2011) Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts. Br J Cancer. 104(3):505-13.
* Chen CC and Borden MA (2011) The role of poly (ethylene glycol) brush architecture in complement activation on targeted microbubble surfaces. Biomaterials. 32(27): 6579-6587.
* Chen CC (2011) Engineering Microbubbles with the Buried-Ligand Architecture for Targeted Ultrasound Molecular Imaging. Columbia University.
* Ghosh A et al. (2010) Effect of lysine supplementation on health and morbidity in subjects belonging to poor peri-urban households in Accra, Ghana. Am J Clin Nutr. 92:928-939
* Woodell-May J et al. (2008) Concentrated Plasma as a Carrier for Stem Cell Delivery. University of Southern California.
* Tong TT et al. (2007) Haemophilus influenzae Survival during Complement-Mediated Attacks Is Promoted by Moraxella catarrhalis Outer Membrane Vesicles. J Infect Dis. 195(11):1661-1670
* Kozyro I et al. (2006) Clinical Value of Autoantibodies Against C1q in Children With Glomerulonephritis. Pediatrics 117(5):1663-1668
ORDERING
Price: $360
Add to Cart:
Data Sheet:
MSDS/SDS:
Image:
Product Image
Product Image
Related Products:
Human Complement C3 Antibody
Human Complement C3 Antibody (Biotin Conjugate)
Human Complement C3 AssayLite Antibody (FITC Conjugate)
Human Complement C3 AssayLite Antibody (RPE Conjugate)
Human Complement C3 AssayLite Antibody (APC Conjugate)
Human Complement C3 AssayLite Antibody (PerCP Conjugate)
Human Complement C3c Antibody
Human Complement C3c Antibody (Biotin Conjugate)
Human Complement C3c AssayLite Antibody (FITC Conjugate)
Human Complement C3c AssayLite Antibody (RPE Conjugate)
Human Complement C3c AssayLite Antibody (APC Conjugate)
Human Complement C3c AssayLite Antibody (PerCP Conjugate)
Human Complement C3d Antibody
Human Complement C3d Antibody (Biotin Conjugate)
Human Complement C3d AssayLite Antibody (FITC Conjugate)
Human Complement C3d AssayLite Antibody (RPE Conjugate)
Human Complement C3d AssayLite Antibody (APC Conjugate)
Human Complement C3d AssayLite Antibody (PerCP Conjugate)
Human Complement C3b Antibody
Human Complement C3b Antibody (Biotin Conjugate)
Human Complement C3b AssayLite Antibody (FITC Conjugate)
Human Complement C3b AssayLite Antibody (RPE Conjugate)
Human Complement C3b AssayLite Antibody (APC Conjugate)
Human Complement C3b AssayLite Antibody (PerCP Conjugate)
Human Complement C3a Antibody
Human Complement C3a Antibody (Biotin Conjugate)
Human Complement C3a AssayLite Antibody (FITC Conjugate)
Human Complement C3a AssayLite Antibody (RPE Conjugate)
Human Complement C3a AssayLite Antibody (APC Conjugate)
Human Complement C3a AssayLite Antibody (PerCP Conjugate)
Human Complement C3 Antibody
Human Complement C3 Antibody (Biotin Conjugate)
Human Complement C3 Monoclonal Antibody
Human Complement C3 Monoclonal Antibody (Biotin Conjugate)
Human Complement C3 Monoclonal AssayLite Antibody (FITC Conjugate)
Human Complement C3 AssayMax ELISA Kit Positive Reference Plasma Control
Human Complement C3 AssayMax ELISA Kit Low (Negative) Reference Control
Human Complement C3 AssayMax ELISA Kit Positive Reference Plasma Control
Human Complement C3b AssayMax ELISA Kit Positive Reference Plasma Control
Human Complement C3 Deficient Plasma (Sodium Citrate)
Human Complement C3 Deficient Plasma (EDTA)
Human Complement C3 Deficient Plasma (Heparin)
Human Complement C3 Deficient Serum
Human Complement C3 AssayMax ELISA Kit (Positive and Low Controls Included)
Human Complement C3 AssayMax ELISA Kit
Human Complement C3 AssayMax ELISA Kit (Positive Control Included)
Human Complement C3b AssayMax ELISA Kit
Human Complement C3b AssayMax ELISA Kit (Positive Control Included)
Human Complement C3d AssayMax ELISA Kit
Human Complement C3d AssayMax ELISA Kit (Positive Control Included)
Human Complement C3 and Complement C4 AssayLite Multiplex Fluorescent Immunoassay Kit
Human Complement C3 AssayLite Fluorescent Immunoassay Kit
Human Complement C3
Human Complement C3b
Human Complement C3d
Human Complement C3c
Powered by Bioz See more details on Bioz

Protocols

  • Sandwich ELISA Protocols

  • Competitive ELISA Protocols

Support

  • Technical Support
  • FAQs
  • Legal Information
  • Privacy Policy

Contact Information

  • 3400 Harry S Truman Blvd, St. Charles, MO 63301-4046, United States

  • (636) 447-9175

  • (636) 395-7419

  • [email protected]

Social Media
Assaypro

All Assaypro products are for research use only and are not intended for diagnostic procedures.

© 2021 Assaypro LLC. All Rights Reserved